SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0000921895-12-001506
Filing Date
2012-07-13
Accepted
2012-07-13 17:02:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT prec14a08511002_07132012.htm PREC14A 257824
  Complete submission text file 0000921895-12-001506.txt   259617
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-35285 | Film No.: 12962288
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 EAST 53RD STREET 31ST FLOOR NEW YORK NY 10022
Business Address 10 EAST 53RD STREET 31ST FLOOR NEW YORK NY 10022 212 630 5072
Mangrove Partners Fund, L.P. (Filed by) CIK: 0001486623 (see all company filings)

IRS No.: 272067192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A